2018
DOI: 10.5853/jos.2018.01627
|View full text |Cite
|
Sign up to set email alerts
|

Prognosis of Acute Intracranial Atherosclerosis-Related Occlusion after Endovascular Treatment

Abstract: Background and PurposeLittle is known about prognosis after endovascular therapy (EVT) for acute large artery occlusion (LAO) caused by underlying intracranial atherosclerotic stenosis (ICAS). Therefore, we investigated the prognosis following EVT according to the underlying etiology of LAO. MethodsPatients from the Acute Stroke due to Intracranial Atherosclerotic occlusion and Neurointervention-Korean Retrospective (ASIAN KR) registry (n=720) were included if their occlusion was in the intracranial anterior c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
105
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
2
2

Relationship

2
5

Authors

Journals

citations
Cited by 100 publications
(109 citation statements)
references
References 43 publications
4
105
0
Order By: Relevance
“…The median age of the patients was higher in the tirofiban group than in the non-tirofiban group (non-tirofiban group versus tirofiban group; 63 [55-75] versus 71 [61-78], p = 0.015). The median initial NIHSS scores (15 [12][13][14][15][16][17][18][19][20][21] versus 14 [10][11][12][13][14][15][16][17][18][19][20], p = 0.322) and the median ASPECTS scores (8 [4.5-9.5] vs. 8 [6][7][8][9], p = 0.530) did not significantly differ between the two groups. Further, the intravenous recombinant tissue plasminogen activator (rtPA) did not significantly differ between the two groups (49.2% versus 33.9%, p = 0.093).…”
Section: Demographics and Baseline Characteristicsmentioning
confidence: 99%
See 1 more Smart Citation
“…The median age of the patients was higher in the tirofiban group than in the non-tirofiban group (non-tirofiban group versus tirofiban group; 63 [55-75] versus 71 [61-78], p = 0.015). The median initial NIHSS scores (15 [12][13][14][15][16][17][18][19][20][21] versus 14 [10][11][12][13][14][15][16][17][18][19][20], p = 0.322) and the median ASPECTS scores (8 [4.5-9.5] vs. 8 [6][7][8][9], p = 0.530) did not significantly differ between the two groups. Further, the intravenous recombinant tissue plasminogen activator (rtPA) did not significantly differ between the two groups (49.2% versus 33.9%, p = 0.093).…”
Section: Demographics and Baseline Characteristicsmentioning
confidence: 99%
“…However, if the occlusion is caused by intracranial atherosclerotic stenosis (ICAS), these MT methods may not be sufficient for recanalization and reperfusion, and rescue treatment are frequently required following MT [6][7][8][9]. Until now, angiographic and clinical outcomes after ERT for ICAS-LVO have been reported to be challenging [10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Underlying ICAS, which should be differentiated from embolism or other etiologies, was de ned based on the remaining xed focal stenosis during EVT. The step-by-step evaluations for differentiation were described previously [11]. Brie y, after con rmation of arterial occlusion, patients with uncommon stroke etiologies, such as dissection, Moyamoya disease, and vasculitis were excluded.…”
Section: Classifying Icas-lvomentioning
confidence: 99%
“…Brie y, after con rmation of arterial occlusion, patients with uncommon stroke etiologies, such as dissection, Moyamoya disease, and vasculitis were excluded. Embolic occlusion was classi ed based on complete vessel recanalization after thrombectomy, and ICAS-related occlusion was classi ed when a remnant stenosis of >70%, or a lesser degree of stenosis with a tendency toward reocclusion and/or ow impairment after thrombectomy was observed [11,17]. This classi cation was further con rmed by repeat angiography during admission.…”
Section: Classifying Icas-lvomentioning
confidence: 99%
See 1 more Smart Citation